Rosomni-Gold 75/75/20: Notes for Doctors and Pharmacists

Rosomni-Gold 75/75/20 is a hard gelatin capsule containing Aspirin IP 75 mg as enteric-coated pellets, Rosuvastatin 20 mg and Clopidogrel 75 mg, supplied as 10 x 10 capsules. It carries the standard Schedule H caution: not to be sold by retail without the prescription of a registered medical practitioner.

At the counter that means verifying the prescriber's details, confirming the strength written matches the pack supplied, and maintaining the sale record your establishment keeps for Schedule H items. Given how similar the names in this range look, read the full strength on the prescription rather than the brand family alone.

A point worth watching: substitution requests are common when a strip runs out mid-course. Because Rosomni-Gold 75/75/20, Rosomni-Gold 75/75/10, Rosomni-A 75/10 and Rosomni-20 differ in clinically meaningful ways, an unplanned swap can drop an antiplatelet agent from a post-stent regimen. Refer the patient back to the prescriber rather than substituting.

The label condition is a cool, dry, dark place not exceeding 25 degrees Celsius, protected from light and moisture.

In practice that means keeping cartons out of direct sunlight and away from display windows, maintaining air conditioning or adequate ventilation in the storage area, and keeping stock off the floor and away from external walls that heat up. During the monsoon, watch for damp in the godown and check cartons for any sign of moisture ingress.

Rotate on a first-expiry-first-out basis and check near-expiry stock at regular intervals. Keep the outer carton with the strips wherever possible so batch and expiry details stay together, and record batch numbers on the bill. If a customer returns a strip with damaged foil, swollen capsules or discolouration, quarantine it and take it up with your distributor rather than reissuing it.

A short, structured conversation at the counter adds real value with this product.

A few interaction and monitoring themes come up repeatedly with this combination.

Clopidogrel is a prodrug requiring CYP2C19 activation, so proton pump inhibitors that inhibit that enzyme are worth flagging when a gastroprotective agent is being added. Concurrent NSAIDs, SSRIs, anticoagulants and other antiplatelets all increase bleeding risk and should prompt a conversation with the prescriber.

On the statin side, gemfibrozil and ciclosporin raise rosuvastatin exposure, certain antiviral agents affect hepatic transporters, and antacids taken simultaneously reduce absorption. Rosuvastatin exposure can be higher in patients of Asian ancestry, and the 20 mg strength warrants caution in significant renal impairment and is not appropriate in active hepatic disease.

Monitoring commonly includes a lipid profile after dose changes, liver enzymes, creatine kinase where muscle symptoms are reported, haemoglobin where occult blood loss is suspected, and glycaemic parameters over time. Prescribers may also review the planned duration of dual antiplatelet therapy against the individual bleeding risk at each visit.

Rosomni-Gold 75/75/20 is marketed in India by EMK Omni Pharma, based in Mysuru, Karnataka. The capsules are manufactured at GMP-certified contract manufacturing units and supplied in 10 x 10 capsule packs.

Pharmacies, hospitals, clinics, stockists and distributors who wish to enquire about availability, stocking or distribution rights for the Cardiac Care range can reach the team through the contact page on the EMK Omni Pharma website, or on WhatsApp at +91 94487 74372.

When enquiring, it helps to mention your establishment name, city, drug licence details and the approximate quantities you deal in, so the response can be matched to your requirement. Enquiries about the sibling products Rosomni-Gold 75/75/10, Rosomni-A 75/10 and Rosomni-20 can be made through the same channels.

This article is for general information only and is not a substitute for advice from a registered medical practitioner.